Aging Disrupts Muscle Stem Cell Function by Impairing Matricellular WISP1 Secretion from Fibro-Adipogenic Progenitors.


Journal

Cell stem cell
ISSN: 1875-9777
Titre abrégé: Cell Stem Cell
Pays: United States
ID NLM: 101311472

Informations de publication

Date de publication:
07 03 2019
Historique:
received: 22 12 2016
revised: 15 10 2018
accepted: 17 12 2018
pmc-release: 07 03 2020
pubmed: 29 1 2019
medline: 24 4 2020
entrez: 29 1 2019
Statut: ppublish

Résumé

Research on age-related regenerative failure of skeletal muscle has extensively focused on the phenotypes of muscle stem cells (MuSCs). In contrast, the impact of aging on regulatory cells in the MuSC niche remains largely unexplored. Here, we demonstrate that aging impairs the function of mouse fibro-adipogenic progenitors (FAPs) and thereby indirectly affects the myogenic potential of MuSCs. Using transcriptomic profiling, we identify WNT1 Inducible Signaling Pathway Protein 1 (WISP1) as a FAP-derived matricellular signal that is lost during aging. WISP1 is required for efficient muscle regeneration and controls the expansion and asymmetric commitment of MuSCs through Akt signaling. Transplantation of young FAPs or systemic treatment with WISP1 restores the myogenic capacity of MuSCs in aged mice and rescues skeletal muscle regeneration. Our work establishes that loss of WISP1 from FAPs contributes to MuSC dysfunction in aged skeletal muscles and demonstrates that this mechanism can be targeted to rejuvenate myogenesis.

Identifiants

pubmed: 30686765
pii: S1934-5909(18)30604-0
doi: 10.1016/j.stem.2018.12.014
pmc: PMC6408230
mid: NIHMS1518846
pii:
doi:

Substances chimiques

CCN Intercellular Signaling Proteins 0
CCN4 protein, human 0
CCN4 protein, mouse 0
Proto-Oncogene Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

433-446.e7

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR044031
Pays : United States
Organisme : CIHR
ID : FDN-148387
Pays : Canada

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

Cell Stem Cell. 2018 Oct 4;23(4):530-543.e9
pubmed: 30290177
Nat Med. 2014 Mar;20(3):265-71
pubmed: 24531379
Curr Neurovasc Res. 2014;11(4):378-89
pubmed: 25219658
Diabetes. 2015 Mar;64(3):856-66
pubmed: 25281430
Nature. 2014 Feb 20;506(7488):316-21
pubmed: 24522534
Curr Top Dev Biol. 2018;126:23-65
pubmed: 29305000
Immunity. 2016 Feb 16;44(2):355-67
pubmed: 26872699
Nat Med. 2015 Jul;21(7):786-94
pubmed: 26053624
Mamm Genome. 2013 Sep 11;:
pubmed: 24022199
Elife. 2015 Dec 19;4:e12997
pubmed: 26687007
J Clin Invest. 2009 Apr;119(4):772-87
pubmed: 19287097
J Biol Chem. 2015 May 29;290(22):14004-18
pubmed: 25864198
Muscles Ligaments Tendons J. 2012 Oct 16;2(3):239-42
pubmed: 23738303
Nat Cell Biol. 2010 Feb;12(2):153-63
pubmed: 20081841
PLoS One. 2015 Dec 02;10(12):e0144230
pubmed: 26629696
Nat Med. 2018 Sep;24(9):1360-1371
pubmed: 30061698
EMBO Mol Med. 2013 Apr;5(4):626-39
pubmed: 23505062
J Clin Invest. 2017 Sep 1;127(9):3510-3520
pubmed: 28783045
Nature. 2016 Dec 8;540(7632):276-279
pubmed: 27894125
Nat Med. 2014 Oct;20(10):1174-81
pubmed: 25194569
Aging Cell. 2010 Oct;9(5):667-84
pubmed: 20701600
Nature. 2012 Oct 18;490(7420):355-60
pubmed: 23023126
BMC Genomics. 2008 Oct 16;9:488
pubmed: 18925949
Cell Stem Cell. 2013 Jan 3;12(1):75-87
pubmed: 23290138
Science. 2016 Jun 17;352(6292):1436-43
pubmed: 27127236
PLoS One. 2013 Aug 15;8(8):e71084
pubmed: 23976982
FASEB J. 2007 Nov;21(13):3737-46
pubmed: 17575261
Development. 2000 Dec;127(23):5059-70
pubmed: 11060232
Cell Stem Cell. 2017 Jan 5;20(1):56-69
pubmed: 27840022
Nat Cell Biol. 2010 Feb;12(2):143-52
pubmed: 20081842
Stem Cell Res. 2016 Jul;17(1):161-9
pubmed: 27376715
Cell Commun Adhes. 2005 Jan-Apr;12(1-2):41-57
pubmed: 16371345
Stem Cells. 2015 Aug;33(8):2456-68
pubmed: 25917344
Cell. 2012 Jun 8;149(6):1298-313
pubmed: 22682250
Science. 2007 Aug 10;317(5839):807-10
pubmed: 17690295
Nature. 2016 Dec 15;540(7633):428-432
pubmed: 27919074
Cell. 2013 Apr 11;153(2):376-88
pubmed: 23582327
Nature. 2008 Jul 24;454(7203):528-32
pubmed: 18552838
Nat Med. 2015 Aug;21(8):854-62
pubmed: 26248268
Skelet Muscle. 2011 May 04;1(1):21
pubmed: 21798099
Nature. 2016 Jan 7;529(7584):37-42
pubmed: 26738589
Nat Med. 2016 Aug;22(8):889-96
pubmed: 27376575
JCI Insight. 2018 Feb 22;3(4):
pubmed: 29467324
Skelet Muscle. 2016 Jan 18;6:1
pubmed: 26783424
Development. 2011 Sep;138(17):3625-37
pubmed: 21828091
Methods Mol Biol. 2018;1686:149-159
pubmed: 29030819
Dev Biol. 2012 Jan 1;361(1):27-38
pubmed: 22037676
Nat Commun. 2014 Jun 10;5:4082
pubmed: 24915299
Cell Stem Cell. 2018 Jan 4;22(1):119-127.e3
pubmed: 29249462
Nat Med. 2014 Mar;20(3):255-64
pubmed: 24531378
Dev Biol. 2006 Jun 1;294(1):50-66
pubmed: 16554047
Nat Med. 2016 Aug;22(8):897-905
pubmed: 27376579
Int J Endocrinol. 2014;2014:309570
pubmed: 24527032
Nat Rev Mol Cell Biol. 2016 May;17(5):267-79
pubmed: 26956195
J Immunol. 2016 Jun 1;196(11):4771-82
pubmed: 27183604
Aging Cell. 2015 Aug;14(4):678-88
pubmed: 26009878
Cell. 2007 Jun 1;129(5):999-1010
pubmed: 17540178
Matrix Biol. 2018 Aug;68-69:533-546
pubmed: 29330021
Bone. 2016 Feb;83:162-170
pubmed: 26555637
Bone. 2009 Jan;44(1):24-31
pubmed: 18835464

Auteurs

Laura Lukjanenko (L)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland; School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL), 1015 Lausanne, Switzerland.

Sonia Karaz (S)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.

Pascal Stuelsatz (P)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.

Uxia Gurriaran-Rodriguez (U)

Sprott Center for Stem Cell Research, Ottawa Hospital Research Institute, Ottawa, ON K1H8L6, Canada; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

Joris Michaud (J)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.

Gabriele Dammone (G)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.

Federico Sizzano (F)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.

Omid Mashinchian (O)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland; School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL), 1015 Lausanne, Switzerland.

Sara Ancel (S)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland; School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL), 1015 Lausanne, Switzerland.

Eugenia Migliavacca (E)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.

Sophie Liot (S)

Institut NeuroMyoGène, Université Claude Bernard Lyon 1, CNRS 5310, INSERM U1217, Lyon, France.

Guillaume Jacot (G)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.

Sylviane Metairon (S)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.

Frederic Raymond (F)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.

Patrick Descombes (P)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.

Alessio Palini (A)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.

Benedicte Chazaud (B)

Institut NeuroMyoGène, Université Claude Bernard Lyon 1, CNRS 5310, INSERM U1217, Lyon, France.

Michael A Rudnicki (MA)

Sprott Center for Stem Cell Research, Ottawa Hospital Research Institute, Ottawa, ON K1H8L6, Canada; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

C Florian Bentzinger (CF)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland; Département de pharmacologie et physiologie, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada.

Jerome N Feige (JN)

Nestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland; School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL), 1015 Lausanne, Switzerland. Electronic address: jerome.feige@rd.nestle.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH